# Alexo Therapeutics Ltd: Form D filing

Alexo Therapeutics Ltd, a biotechnology company in Dublin 2, Ireland, filed a Form D with the SEC in 2015. The latest, on May 21, 2015, reports $18 million sold of a $36 million offering to 14 investors.

Find out what Alexo Therapeutics Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Alexo%20Therapeutics%20Ltd%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Alexo%20Therapeutics%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Falexo-therapeutics-ltd-1642930)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Alexo%20Therapeutics%20Ltd%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Alexo%20Therapeutics%20Ltd&page=%2Fdata%2Fform-d%2Fcompany%2Falexo-therapeutics-ltd-1642930)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: C/O BRADWELL LIMITED, ARTHUR COX BUILDING, EARLSFORT TERRACE, Dublin 2, Ireland, 00000
- Phone: (353) 161-8000
- Industry: Biotechnology
- Entity type: Other (Private company limited by shares.)
- Incorporated in: Ireland
- Year incorporated: 2015
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1642930

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 21, 2015 | New notice | $36,005,425 | $18,022,500 | $17,982,925 | 14 | May 8, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1642930/000164293015000001/0001642930-15-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Corey Goodman | Director |  |
| Jaume Pons | Director |  |
| n/a Bradwell Limited | Executive Officer |  |
| Jason Lettman | Director |  |

[Every Form D from the week of May 18, 2015](https://specstream.ai/data/form-d/week/2015-05-18) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Alexo Therapeutics Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).